Cargando…

Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin

The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with...

Descripción completa

Detalles Bibliográficos
Autores principales: Leri, Manuela, Bemporad, Francesco, Oropesa‐Nuñez, Reinier, Canale, Claudio, Calamai, Martino, Nosi, Daniele, Ramazzotti, Matteo, Giorgetti, Sofia, Pavone, Francesco S., Bellotti, Vittorio, Stefani, Massimo, Bucciantini, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956941/
https://www.ncbi.nlm.nih.gov/pubmed/26990223
http://dx.doi.org/10.1111/jcmm.12833
_version_ 1782444110131494912
author Leri, Manuela
Bemporad, Francesco
Oropesa‐Nuñez, Reinier
Canale, Claudio
Calamai, Martino
Nosi, Daniele
Ramazzotti, Matteo
Giorgetti, Sofia
Pavone, Francesco S.
Bellotti, Vittorio
Stefani, Massimo
Bucciantini, Monica
author_facet Leri, Manuela
Bemporad, Francesco
Oropesa‐Nuñez, Reinier
Canale, Claudio
Calamai, Martino
Nosi, Daniele
Ramazzotti, Matteo
Giorgetti, Sofia
Pavone, Francesco S.
Bellotti, Vittorio
Stefani, Massimo
Bucciantini, Monica
author_sort Leri, Manuela
collection PubMed
description The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with respect to the wild‐type protein. In this study, we characterized the D76N b2M aggregation path and performed an unprecedented analysis of the biochemical mechanisms underlying aggregate cytotoxicity. We showed that, contrarily to what expected from other amyloid studies, early aggregates of the mutant are not the most toxic species, despite their higher surface hydrophobicity. By modulating ganglioside GM1 content in cell membrane or synthetic lipid bilayers, we confirmed the pivotal role of this lipid as aggregate recruiter favouring their cytotoxicity. We finally observed that the aggregates bind to the cell membrane inducing an alteration of its elasticity (with possible functional unbalance and cytotoxicity) in GM1‐enriched domains only, thus establishing a link between aggregate‐membrane contact and cell damage.
format Online
Article
Text
id pubmed-4956941
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49569412016-08-03 Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin Leri, Manuela Bemporad, Francesco Oropesa‐Nuñez, Reinier Canale, Claudio Calamai, Martino Nosi, Daniele Ramazzotti, Matteo Giorgetti, Sofia Pavone, Francesco S. Bellotti, Vittorio Stefani, Massimo Bucciantini, Monica J Cell Mol Med Original Articles The first genetic variant of β(2)‐microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to aggregate with respect to the wild‐type protein. In this study, we characterized the D76N b2M aggregation path and performed an unprecedented analysis of the biochemical mechanisms underlying aggregate cytotoxicity. We showed that, contrarily to what expected from other amyloid studies, early aggregates of the mutant are not the most toxic species, despite their higher surface hydrophobicity. By modulating ganglioside GM1 content in cell membrane or synthetic lipid bilayers, we confirmed the pivotal role of this lipid as aggregate recruiter favouring their cytotoxicity. We finally observed that the aggregates bind to the cell membrane inducing an alteration of its elasticity (with possible functional unbalance and cytotoxicity) in GM1‐enriched domains only, thus establishing a link between aggregate‐membrane contact and cell damage. John Wiley and Sons Inc. 2016-03-18 2016-08 /pmc/articles/PMC4956941/ /pubmed/26990223 http://dx.doi.org/10.1111/jcmm.12833 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Leri, Manuela
Bemporad, Francesco
Oropesa‐Nuñez, Reinier
Canale, Claudio
Calamai, Martino
Nosi, Daniele
Ramazzotti, Matteo
Giorgetti, Sofia
Pavone, Francesco S.
Bellotti, Vittorio
Stefani, Massimo
Bucciantini, Monica
Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title_full Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title_fullStr Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title_full_unstemmed Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title_short Molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
title_sort molecular insights into cell toxicity of a novel familial amyloidogenic variant of β2‐microglobulin
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956941/
https://www.ncbi.nlm.nih.gov/pubmed/26990223
http://dx.doi.org/10.1111/jcmm.12833
work_keys_str_mv AT lerimanuela molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT bemporadfrancesco molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT oropesanunezreinier molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT canaleclaudio molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT calamaimartino molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT nosidaniele molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT ramazzottimatteo molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT giorgettisofia molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT pavonefrancescos molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT bellottivittorio molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT stefanimassimo molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin
AT bucciantinimonica molecularinsightsintocelltoxicityofanovelfamilialamyloidogenicvariantofb2microglobulin